It's Monday, May 18th. Welcome to Market Foolery. I'm Chris Hill joining me today, the one and only Bill Barker. Thanks for being here.

Thanks for having me. We're going to talk some retail. We are going to dip into the

full mail bag, but we are going to start with the stock of the day, and that is

Moderna, shares of Moderna up more than 20% after the biotech company announced positive interim data on a phase one study of its coronavirus vaccine.

These are human trials, so that's encouraging. I should point out not a lot of humans.

This is not one of those tests that's been done on thousands or even tens of thousands of people.

But still, this is encouraging,

both for Moderna and I think for the overall market.

Yeah, positive results from the phase one trial, which are largely very positive results.

Let's put it that way.

The market certainly is putting it that way.

And so phase one trial you're dealing with the safety primarily of what you're going to be studying and you do that in the smallest group

TENS it was 45 in this case then in phase two, you move that

to the trial to hundreds and in phase three to thousands.

So 45 people on various different levels of the test vaccine dose all showed positive antibodies, or good antibodies.

And that's good news.

They can move forward and they hope to be in phase three

or plan to be in phase three in July and then to if everything goes

well from here to there and in phase three have a vaccine sometime in 2021.

It really is amazing to see the reaction in the market because again it's not just Moderna with the stock up 20% but you

look at things like shares of Disney are up 8% this morning. Royal Caribbean, Carnival

Cruise line.

...